These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 10413299

  • 1. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
    Rosati AM, Traversa U.
    Biochem Pharmacol; 1999 Aug 15; 58(4):623-32. PubMed ID: 10413299
    [Abstract] [Full Text] [Related]

  • 2. Zinc and cadmium ions differently modulates A1 adenosine receptors.
    Traversa U, Rosati A.
    Acta Physiol Hung; 1996 Aug 15; 84(4):465-7. PubMed ID: 9328633
    [Abstract] [Full Text] [Related]

  • 3. Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.
    Klotz KN, Lohse MJ, Schwabe U.
    J Biol Chem; 1988 Nov 25; 263(33):17522-6. PubMed ID: 3182861
    [Abstract] [Full Text] [Related]

  • 4. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
    Garritsen A, Ijzerman AP, Beukers MW, Soudijn W.
    Biochem Pharmacol; 1990 Aug 15; 40(4):835-42. PubMed ID: 2143656
    [Abstract] [Full Text] [Related]

  • 5. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S.
    Br J Pharmacol; 1996 Apr 15; 117(7):1381-6. PubMed ID: 8730729
    [Abstract] [Full Text] [Related]

  • 6. The amphiphilic peptide adenoregulin enhances agonist binding to A1-adenosine receptors and [35S]GTP gamma S to brain membranes.
    Moni RW, Romero FS, Daly JW.
    Cell Mol Neurobiol; 1995 Aug 15; 15(4):465-93. PubMed ID: 8565049
    [Abstract] [Full Text] [Related]

  • 7. Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
    Finlayson K, Maemoto T, Butcher SP, Sharkey J, Olverman HJ.
    Acta Pharmacol Sin; 2003 Aug 15; 24(8):729-40. PubMed ID: 12904270
    [Abstract] [Full Text] [Related]

  • 8. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
    Mazzoni MR, Giusti L, Rossi E, Taddei S, Lucacchini A.
    Biochim Biophys Acta; 1997 Feb 21; 1324(1):159-70. PubMed ID: 9059509
    [Abstract] [Full Text] [Related]

  • 9. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
    Rivkees SA, Lasbury ME, Barbhaiya H.
    J Biol Chem; 1995 Sep 01; 270(35):20485-90. PubMed ID: 7657625
    [Abstract] [Full Text] [Related]

  • 10. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.
    Br J Pharmacol; 1997 Nov 01; 122(6):1202-8. PubMed ID: 9401787
    [Abstract] [Full Text] [Related]

  • 11. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP, Curtis AR, Kendall DA, Hill SJ.
    Br J Pharmacol; 1994 Dec 01; 113(4):1501-7. PubMed ID: 7889308
    [Abstract] [Full Text] [Related]

  • 12. Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum.
    Concas A, Mascia MP, Cuccheddu T, Floris S, Mostallino MC, Perra C, Satta S, Biggio G.
    Pharmacol Biochem Behav; 1996 Feb 01; 53(2):249-55. PubMed ID: 8808128
    [Abstract] [Full Text] [Related]

  • 13. Role of histidine residues in agonist and antagonist binding sites of A1 adenosine receptor.
    Allende G, Casadó V, Mallol J, Franco R, Lluis C, Canela EI.
    J Neurochem; 1993 Apr 01; 60(4):1525-33. PubMed ID: 8455039
    [Abstract] [Full Text] [Related]

  • 14. 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.
    Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec 01; 340(6):679-83. PubMed ID: 2615857
    [Abstract] [Full Text] [Related]

  • 15. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR, Lazareno S, Birdsall NJ.
    Br J Pharmacol; 1996 Apr 01; 117(7):1521-9. PubMed ID: 8730749
    [Abstract] [Full Text] [Related]

  • 16. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
    Concas A, Santoro G, Mascia MP, Maciocco E, Dazzi L, Ongini E, Biggio G.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):844-51. PubMed ID: 8246158
    [Abstract] [Full Text] [Related]

  • 17. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
    Peachey JA, Hourani SM, Kitchen I.
    Br J Pharmacol; 1996 Nov 01; 119(5):949-58. PubMed ID: 8922745
    [Abstract] [Full Text] [Related]

  • 18. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A, Townsend-Nicholson A, Beukers MW, Schofield PR, IJzerman AP.
    Biochem Pharmacol; 1998 Dec 01; 56(11):1437-45. PubMed ID: 9827575
    [Abstract] [Full Text] [Related]

  • 19. Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium.
    Morey TE, Belardinelli L, Dennis DM.
    Br J Pharmacol; 1998 Apr 01; 123(7):1425-33. PubMed ID: 9579739
    [Abstract] [Full Text] [Related]

  • 20. Modification of the peripheral-type benzodiazepine receptor by arachidonate, diethylpyrocarbonate and thiol reagents.
    Skowroński R, Beaumont K, Fanestil DD.
    Eur J Pharmacol; 1987 Nov 17; 143(3):305-14. PubMed ID: 2826190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.